bioRxivBioinformaticsPreprint
Orthogonal linear separation analysis: an approach to decompose the complex effect of a perturbagen
Tadahaya MizunoiD, Setsuo Kinoshita, Shotaro MaederaiD, Takuya ItoiD, Hiroyuki KusuharaiD
Abstract
Drugs have multiple, not single, effects. Decomposition of drug effects into basic components helps us to understand the pharmacological properties of a drug and contributes to drug discovery. We have extended factor analysis and developed a novel profile data analysis method, orthogonal linear separation analysis (OLSA). OLSA contracted 11,911 genes to 118 factors from transcriptome data of MCF7 cells treated with 318 compounds in Connectivity Map. Ontology of the main genes constituting the factors detected significant enrichment of the ontology in 65 of 118 factors and similar results were obtained in two other data sets. One factor discriminated two Hsp90 inhibitors, geldanamycin and radicicol, while clustering analysis could not. Doxorubicin was estimated to inhibit Na+/K+ ATPase, one of the suggested mechanisms of doxorubicin-induced cardiotoxicity. Based on the factor including PI3K/AKT/mTORC1 inhibition activity, 5 compounds were predicted to be novel autophagy inducers, and other analysis including western blotting revealed that 4 of the 5 actually induced autophagy. These findings indicate the potential of OLSA to decompose the effects of a drug and identify its basic components. (<175 words)
- organism: human
- assay: bulk RNA-seq
- research focus: differential expression
- research focus: drug response / drug discovery
- research focus: benchmarking
- approach: statistical model
- Citations
- 0
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Comparative study of the mechanism of natural compounds with similar structures using docking and transcriptome data for improving in silico herbal medicine experimentations
Musun Park, Su‐Jin Baek, … Seongwon Cha·Briefings in BioinformaticsPeer-reviewed·Sep 14, 2023
- High Dimensionality Reduction by Matrix Factorization for Systems Pharmacology
Adel Mehrpooya, Farid Saberi-Movahed, … Iman Tavassoly·Briefings in BioinformaticsPeer-reviewed·Sep 8, 2021
- Compound Mechanism of Action and Polypharmacology can be Elucidated by Large-Scale Perturbational Profile Analysis
Lucas ZhongMing Hu, Tal Hirschhorn, … Andrea Califano·bioRxiv·Oct 8, 2023
- Non-oncology drugs are a source of previously unappreciated anti-cancer activity
S. M. Corsello, R. T. Nagari, … T. R. Golub·bioRxiv·Aug 9, 2019
- Pharmacoproteomic profiling identifies secreted markers for aberrant drug action
Sascha Knecht, Mathias Kalxdorf, … Marcus Bantscheff·bioRxiv·Oct 16, 2024
- Fractional Deletion Of Compound Kushen Injection, A Natural Compound Mixture, Indicates Cytokine Signaling Pathways Are Critical For Its Perturbation Of The Cell Cycle.
T. N. Aung, S. Nourmohammadi, … D. L. Adelson·bioRxiv·Dec 9, 2018